States divided on Medicaid
Medicaid expansion is driving a wedge between legislatures and governors, and increasingly between states and their citizens.
Medicaid expansion is driving a wedge between legislatures and governors, and increasingly between states and their citizens.
Last week, protesters marched in Austin, Texas, to voice their opposition to Governor Rick Perry’s vow to opt-out of Medicaid expansion. Nearly one in four Texans are uninsured, the highest percentage in the nation.
In Florida, where the GOP claims the governor’s office and both houses, state Republicans are divided over whether to take the federal funds or let them go to other states that do opt-in.
Florida Speaker of the House Will Weatherford, an expansion opponent, revealed that when he was a child, his family relied on safety-net and charity services for cancer treatment for his younger brother. A local newspaper reporter also discovered that the family received support from a program that used Medicaid funds, which Weatherford disputed.
However, Florida Governor Rick Scott has indicated he would support the expansion in spite of his opposition to the Patient Protection and Affordable Care Act. A senate committee studied the impact Medicaid expansion would have on the state. Although it would cost $5.2 billion, Florida would gain $51 billion in federal aid over the next 10 years if the state expanded Medicaid.
So far at least seven Republican governors have said they will participate in the expansion.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
